Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer

about

Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer

Item

http://www.wikidata.org/entity/Q57809354

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Genetic and immunological biom ...... ence in stage III colon cancer

@en

Genetic and immunological biom ...... ence in stage III colon cancer

@nl

type

Item

label

Genetic and immunological biom ...... ence in stage III colon cancer

@en

Genetic and immunological biom ...... ence in stage III colon cancer

@nl

prefLabel

Genetic and immunological biom ...... ence in stage III colon cancer

@en

Genetic and immunological biom ...... ence in stage III colon cancer

@nl

P1476

Genetic and immunological biom ...... ence in stage III colon cancer

@en

P2093

Alexander Balmert

http://www.w3.org/2001/XMLSchema#string

Andreas Sperlich

http://www.w3.org/2001/XMLSchema#string

Anna Mur

http://www.w3.org/2001/XMLSchema#string

Dietrich Doll

http://www.w3.org/2001/XMLSchema#string

Dirk Wilhelm

http://www.w3.org/2001/XMLSchema#string

Fabian Franke

http://www.w3.org/2001/XMLSchema#string

Gisela Keller

http://www.w3.org/2001/XMLSchema#string

Klaus-Peter Janssen

http://www.w3.org/2001/XMLSchema#string

Michael Respondek

http://www.w3.org/2001/XMLSchema#string

Sabine Bauer

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Cancer statistics, 2016

MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer.

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

MicroRNA classifier and nomogram for metastasis prediction in colon cancer.

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers.

P2888

s12885-018-4940-2

P304

998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4940-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Helmut Friess

P577

2018-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107731641

http://www.w3.org/2001/XMLSchema#string

P698

30340556

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6194664

http://www.w3.org/2001/XMLSchema#string